APA (7th ed.) Citation

ZF, A., LM, Ø., M, Ø., KY, J., JB, J., J, H., . . . ML, H. (2026). Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis. RMD open, 12(2), . https://doi.org/10.1136/rmdopen-2025-006477

Chicago Style (17th ed.) Citation

ZF, Ahmadzay, et al. "Impact of Cardiometabolic Comorbidities on Clinical Characteristics, Prescription Patterns and Retention Rate of First B/tsDMARD Treatment in 5299 European Real-world Patients with Psoriatic Arthritis." RMD Open 12, no. 2 (2026). https://doi.org/10.1136/rmdopen-2025-006477.

MLA (9th ed.) Citation

ZF, Ahmadzay, et al. "Impact of Cardiometabolic Comorbidities on Clinical Characteristics, Prescription Patterns and Retention Rate of First B/tsDMARD Treatment in 5299 European Real-world Patients with Psoriatic Arthritis." RMD Open, vol. 12, no. 2, 2026, https://doi.org/10.1136/rmdopen-2025-006477.